Grapefruit Juice and Verapamil : A Toxic CocktailPILIAI, Unnikrishnan; MUZAFFAR, Jameel; SEN, Sandeep et al.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 3, pp 308-309, issn 0038-4348, 2 p.Article

Evaluation of the Effectiveness of Sugammadex for Verapamil IntoxicationOZBILGIN, Sule; OZBILGIN, Mucahit; KUCUKOZTAS, Beyza et al.Basic & clinical pharmacology & toxicology (Print). 2013, Vol 113, Num 4, pp 280-285, issn 1742-7835, 6 p.Article

Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamilWANG, Ying-Hong; JONES, David R; HALL, Stephen D et al.Drug metabolism and disposition. 2005, Vol 33, Num 5, pp 664-671, issn 0090-9556, 8 p.Article

Verapamil for the treatment of acute mania : A double-blind, placebo-controlled trialJANICAK, P. G; SHARMA, R. P; PANDEY, G et al.The American journal of psychiatry. 1998, Vol 155, Num 7, pp 972-973, issn 0002-953XArticle

Effects of the antianginal drug fendiline on Ca²⁺ movement in hepatoma cellsCHENG, J-S; WANG, J-L; LO, Y-K et al.Human & experimental toxicology. 2001, Vol 20, Num 7, pp 359-364, issn 0960-3271Article

Determination of verapamil in pharmaceutical formulations using atomic emission spectrometryKHALIL, Sabry; KELZIEH, Ahmed.Journal of pharmaceutical and biomedical analysis. 2002, Vol 27, Num 1-2, pp 123-131, issn 0731-7085Article

Using trade names: A risk factor for accidental drug overdoseSCHWAB, Matthias; OETZEL, Carsten; MÖRIKE, Klaus et al.Archives of internal medicine (1960). 2002, Vol 162, Num 9, pp 1065-1066, issn 0003-9926Article

Determination of fendiline and gallopamil by capillary isotachophoresisBUZINKAIOVA, Tatiana; POLONSKY, Jozef; SKACANI, Ivan et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 757, Num 2, pp 215-220, issn 1387-2273Article

Verapamil metabolite exposure in older and younger men during steady-state oral verapamil administrationABERNETHY, D. R; WAINER, I. W; ANACLETO, A. I et al.Drug metabolism and disposition. 2000, Vol 28, Num 7, pp 760-765, issn 0090-9556Article

Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular DrugsADAMS, Kristin N; SZUMOWSKI, John D; RAMAKRISHNAN, Lalita et al.The Journal of infectious diseases. 2014, Vol 210, Num 3, pp 456-466, issn 0022-1899, 11 p.Article

Hemodynamic Stability After Intraarterial Injection of Verapamil for Cerebral VasospasmFLEXMAN, Alana M; RYERSON, Christopher J; TALKE, Pekka O et al.Anesthesia and analgesia. 2012, Vol 114, Num 6, pp 1292-1296, issn 0003-2999, 5 p.Article

Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. I: conceptual and numerical issuesPOPOVIC, J.European journal of drug metabolism and pharmacokinetics. 2006, Vol 31, Num 2, pp 79-85, issn 0378-7966, 7 p.Article

Effect of hydroxypropyl-β-cyclodextrin and ph on the solubility of Levemopamil HCIMCCANDLESS, R; YALKOWSKY, S. H.Journal of pharmaceutical sciences. 1998, Vol 87, Num 12, pp 1639-1642, issn 0022-3549Article

Bioavailability assessment from pharmacologic data : Method and clinical evaluationSTAGNI, G; SHEPHERD, A. M. M; LIU, Y et al.Journal of pharmacokinetics and biopharmaceutics. 1997, Vol 25, Num 3, pp 349-362, issn 0090-466XConference Paper

Verapamil: identification of novel metabolites in cultures of primary human hepatocytes and human urine by LC-MSⁿ and LC-NMRBORLAK, J; WALLES, M; ELEND, M et al.Xenobiotica (London. Print). 2003, Vol 33, Num 6, pp 655-676, issn 0049-8254, 22 p.Article

The effect of gender on the pharmacokinetics of verapamil and norverapamil in humanDADASHZADEH, S; JAVADIAN, B; SADEGHIAN, S et al.Biopharmaceutics & drug disposition. 2006, Vol 27, Num 7, pp 329-334, issn 0142-2782, 6 p.Article

Novel chewable sustained-release tablet containing verapamil hydrochlorideEL-GAZAYERLY, Omaima N; RAKKANKA, Vipaporn; AYRES, James W et al.Pharmaceutical development and technology. 2004, Vol 9, Num 2, pp 181-188, issn 1083-7450, 8 p.Article

Multidimensional on-line sample preparation of verapamil and its metabolites by a molecularly imprinted polymer coupled to liquid chromatography-mass spectrometryMULLETT, Wayne M; WALLES, Markus; LEVSEN, Karsten et al.Journal of chromatography. B. 2004, Vol 801, Num 2, pp 297-306, issn 1570-0232, 10 p.Article

Effects of quinidine and verapamil on human cardiovascular α₁-AdrenoceptorsSHIBATA, K; HIRASAWA, A; FOGLAR, R et al.Circulation (New York, N.Y.). 1998, Vol 97, Num 13, pp 1227-1230, issn 0009-7322Article

Predictors of Mortality in Verapamil Overdose: Usefulness of Serum Verapamil ConcentrationsMEGARBANE, Bruno; KARYO, Souheil; ABIDI, Khalid et al.Basic & clinical pharmacology & toxicology (Print). 2011, Vol 108, Num 6, pp 385-389, issn 1742-7835, 5 p.Article

Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjectsJIN, Y; WANG, Y.-H; MIAO, J et al.Clinical pharmacology and therapeutics. 2007, Vol 82, Num 5, pp 579-585, issn 0009-9236, 7 p.Article

Results of the controlled ONset verapamil investigation of cardiovascular endpoints (CONVINCE) trial by geographical regionBLACK, Henry R; ELLIOTT, William J; SLEIGHT, Peter et al.Journal of hypertension. 2005, Vol 23, Num 5, pp 1099-1106, issn 0263-6352, 8 p.Article

St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolismTANNERGREN, Christer; ENGMAN, Helena; KNUTSON, Lars et al.Clinical pharmacology and therapeutics. 2004, Vol 75, Num 4, pp 298-309, issn 0009-9236, 12 p.Article

Pharmacokinetics of verapamil in overdoseKIVISTÖ, K. T; NEUVONEN, P. J; TARSSANEN, L et al.Human & experimental toxicology. 1997, Vol 16, Num 1, pp 35-37, issn 0960-3271Conference Paper

Hyperprolactinaemia and verapamil : prevalence and potential association with hypogonadism in menROMEO, J. H; DOMBROWSKI, R; KWAK, Y. S et al.Clinical endocrinology (Oxford. Print). 1996, Vol 45, Num 5, pp 571-575, issn 0300-0664Article